Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Improperly Attempting to Circumvent the Learned Intermediary Doctrine: Challenging the Adequacy of Warnings to Physicians
The learned intermediary doctrine is one of the most important doctrines for medical device and pharmaceutical drug defendants in product liability cases because under the doctrine, they are often able to obtain summary judgment on failure to warn claims. (The learned intermediary doctrine has been adopted and recognized in at least 45 states. See Larkin v. Pfizer, Inc., 153 S.W.3d 758, 767 (Ky. 2005).) The learned intermediary doctrine provides that a manufacturer, designer or distributor of a medical device or pharmaceutical drug does not have a duty to directly warn patients of possible dangers associated with the use of the device or drug. See Presto v. Sandoz Pharm. Corp., 487 S.E.2d 70 (Ga. Ct. App. 1997). Rather, “'a warning as to possible danger in its use to the prescribing physician is sufficient.'” Id. at 73. As noted in Restatement (Third) of Torts:
The rationale supporting this 'learned intermediary' rule is that only health-care professionals are in a position to understand the significance of the risks involved and to assess the relative advantages and disadvantages of a given form of prescription-based therapy. The duty then devolves on the health-care provider to supply to the patient such information as is deemed appropriate under the circumstances so that the patient can make an informed choice as to therapy. Restatement (Third) of Torts: Prods. Liab. '6 cmt. b.
In addition, courts throughout the country have noted that the learned intermediary doctrine is a sound and rational doctrine because: 1) “manufacturers lack effective means to communicate directly with each patient” and 2) “imposing a duty to warn upon the manufacturer would unduly interfere with the physician-patient relationship.” Larkin v. Pfizer, Inc., 153 S.W.3d 758, 764 (Ky. 2005). Consistent with these policies, courts have found that the learned intermediary doctrine applies not only to pharmaceutical drugs, but to medical devices as well, because medical devices are available only upon “prescription, application (insertion) and supervision of a physician.” Lance v. Am. Edwards Labs., 452 S.E.2d 185, 186 (Ga. Ct. App. 1994). See also Cather v. Catheter Tech. Corp., 753 F. Supp. 634, 640 (S.D. Miss. 1991).
Plaintiffs often attempt to circumvent the learned intermediary doctrine and defeat summary judgment on failure to warn claims by arguing that there is an issue of fact as to whether the warning the pharmaceutical or medical device defendant provided physicians was “adequate.” Courts, however, have consistently rejected such attempts and have held that defendants' warnings to physicians may be declared adequate as a matter of law.
The DOJ's Corporate Enforcement Policy: One Year Later
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
The DOJ's New Parameters for Evaluating Corporate Compliance Programs
The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.
Use of Deferred Prosecution Agreements In White Collar Investigations
This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.
Bankruptcy Sales: Finding a Diamond In the Rough
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
A Lawyer's System for Active Reading
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.